Travera is an oncology diagnostics startup transforming how oncologists make treatment decisions. Its Rapid Therapy Guidance (RTG) Test, developed with MIT technology, evaluates a wide range of FDA-approved therapies against a patient’s unique tumor cells, providing personalized treatment recommendations within two days. This breakthrough enables oncologists to make faster, evidence-based decisions and improve patient outcomes.
As Travera prepared for commercialization, the company needed a proven commercial leader to guide market entry, strengthen relationships with oncologists, and drive adoption of this innovative diagnostic test.
Travera was seeking assistance with its go-to-market strategy and was contracting with MDisrupt to develop an Advisory Board to provide guidance on going to market in the oncology space. Throughout this process, MDisrupt identified the need for a commercial leader who could transform a promising startup into the leading cancer therapy guidance company in the marketplace.
Hiring can be a long and involved process, particularly candidate sourcing. MDisrupt identified the need for a commercial leader who could transform a promising startup into the leading cancer therapy guidance company in the marketplace.
Travera turned to MDisrupt’s Health Expert Hire solution to accelerate its search for a commercial leader. Leveraging its network of thousands of pre-vetted healthcare executives, MDisrupt:
As a result Travera was able to:
For early-stage diagnostics companies, filling a mission-critical leadership role can determine whether they scale quickly or stall out. By using MDisrupt’s Platform, Travera accelerated its hiring process and gained the expertise needed to execute its go-to-market strategy. With this strategic hire, Travera now has the leadership to strengthen relationships with oncologists and bring its innovative cancer diagnostics to market efficiently.
